Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Baumert

Showing results (31-40 of 385) with videos related to

Pageof 39
Sort By:
Hepatology International|April 7, 2016
Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antiviralsChe C Colpitts, Thomas F Baumert
Pflugers Archiv : European Journal of Physiology|November 26, 2016
Claudins in viral infection: from entry to spreadChe C Colpitts, Thomas F Baumert
Journal of Hepatology|December 20, 2005
Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied researchMirjam B Zeisel, Thomas F Baumert
Cellular and Molecular Gastroenterology and Hepatology|December 12, 2025
The Use of Human Liver Chimeric Mice to Study Hepatitis C Virus Antibody Escape: Implications for Vaccine DevelopmentChe C Colpitts, Thomas F Baumert
Hepatology (Baltimore, Md.)|May 27, 2016
Translation and protein expression of lncRNAs: Impact for liver disease and hepatocellular carcinomaMirjam B Zeisel, Thomas F Baumert
The New England Journal of Medicine|April 12, 2014
Curing chronic hepatitis C--the arc of a medical triumphRaymond T Chung, Thomas F Baumert
Hepatology (Baltimore, Md.)|October 22, 2024
Fine-tuning of hepatitis C virus immune evasion through hypervariable region 1 insertionsChe C Colpitts, Thomas F Baumert
Cell Host & Microbe|January 11, 2024
The gut microbiome as a guidepost for infection risk in liver transplantationAngelica T Vieira, Thomas F Baumert
Journal of Virology|June 25, 2010
Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cellsMélanie Lambotin, Thomas F Baumert, Heidi Barth
Cells|April 9, 2020
Liver Fibrosis: Mechanistic Concepts and Therapeutic PerspectivesNatascha Roehlen, Emilie Crouchet, Thomas F Baumert
Pageof 39

Showing results (31-40 of 385) with videos related to

Sort By:
Pageof 39
Hepatology International|April 7, 2016
Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antiviralsChe C Colpitts, Thomas F Baumert
Pflugers Archiv : European Journal of Physiology|November 26, 2016
Claudins in viral infection: from entry to spreadChe C Colpitts, Thomas F Baumert
Journal of Hepatology|December 20, 2005
Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied researchMirjam B Zeisel, Thomas F Baumert
Cellular and Molecular Gastroenterology and Hepatology|December 12, 2025
The Use of Human Liver Chimeric Mice to Study Hepatitis C Virus Antibody Escape: Implications for Vaccine DevelopmentChe C Colpitts, Thomas F Baumert
Hepatology (Baltimore, Md.)|May 27, 2016
Translation and protein expression of lncRNAs: Impact for liver disease and hepatocellular carcinomaMirjam B Zeisel, Thomas F Baumert
The New England Journal of Medicine|April 12, 2014
Curing chronic hepatitis C--the arc of a medical triumphRaymond T Chung, Thomas F Baumert
Hepatology (Baltimore, Md.)|October 22, 2024
Fine-tuning of hepatitis C virus immune evasion through hypervariable region 1 insertionsChe C Colpitts, Thomas F Baumert
Cell Host & Microbe|January 11, 2024
The gut microbiome as a guidepost for infection risk in liver transplantationAngelica T Vieira, Thomas F Baumert
Journal of Virology|June 25, 2010
Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cellsMélanie Lambotin, Thomas F Baumert, Heidi Barth
Cells|April 9, 2020
Liver Fibrosis: Mechanistic Concepts and Therapeutic PerspectivesNatascha Roehlen, Emilie Crouchet, Thomas F Baumert
Pageof 39